ARTICLE | Company News

Myriad Genetics other research news

September 19, 1994 7:00 AM UTC

Company researchers and collaborators, including Eli Lilly and Co., have cloned a gene linked with breast cancer after pinpointing its location on chromosome 17.

A screening test based on the gene, which would detect less than half of the inherited forms of the disease (2 to 3 percent of all breast cancers), could be ready in six months, but the company is emphasizing a more conservative estimate of one to two years. ...